AKT1 and cervical cancer: Interestingly, cervix cancer-derived cells treated with the PI3K inhibitor LY294004 and the proteasome inhibitor MG132 led to induced a G1 and a G2/M cell cycle arrest, respectively [38], signifying that the PI3K/AKT signaling is also linked to cell cycle progression in cancers.